Business Wire

NAB Show 2025 Opens Tomorrow - Set to Define the Future of Content and Entertainment

Share

NAB Show 2025 kicks off on Saturday, April 5 with exhibits opening April 6, showcasing innovation that will define the content and entertainment landscape and shape the future of storytelling. From AI-driven tools to the creator economy, sports, cloud virtualization, and streaming/OTT, the show floor and conference program will highlight the technologies driving innovation across industries. As the world’s largest gathering of media, technology, and entertainment professionals, NAB Show 2025 runs April 5 - 9 at the Las Vegas Convention Center and expects more than 60,000 registered attendees.

“The future of content and entertainment will take center stage at NAB Show 2025 – redefining how content is created, distributed, and consumed around the world,” said Karen Chupka, EVP of Global Connections and Events, NAB. “This show has been successfully reimagined as a home for content creators of all types - from social media to television to the big screen and it delivers on that promise by showcasing cutting-edge innovation that will further evolve the art of storytelling across all mediums.”

Show Floor and Exhibits

The NAB Show exhibit floor will feature nearly 1,100 companies, including 125 first-time exhibitors. Notable brands include Adobe, AWS, AT&T Business, Blackmagic, Canon, Cisco, Dell Technologies, Fujifilm, Intel, Microsoft, Nikon, Quantum Corporation, Riedel, Sony, and Verizon Business.

Emerging tech and startups will be front and center with new exhibit areas including:

  • Startup Stage in PropelME: In partnership with Fabric.ai this area will showcase 22 early-stage startups, with 80% of the companies showing AI technologies.
  • AI Innovation Pavilion: Featuring cutting-edge AI solutions, this premier destination is where industry leaders and decision-makers will connect, explore innovations, and network.
  • Premiere Park: This dedicated area will feature first-time exhibitors spotlighting new technologies and services.
  • Sports Business Hub: Featuring the latest tools and tech for audience engagement and monetizing the fan experience.

Conference Program and Speakers

NAB Show conference program will feature 550 sessions highlighting the latest trends in business, creativity, production, and technology. New session tracks include:

  • Business of Entertainment: Produced in partnership with The Ankler, this two-day track will bring together Hollywood’s top dealmakers and key thought leaders who are driving change and adopting future-focused strategies and solutions. Topics include media dealmaking, content bundles, new advertising models, the state of production, the intersection of Hollywood and the creator economy, and emerging consumer and audience trends.
  • Sports Summit: The Future of Sports Rights and Fan Experience: This three-day event will explore the rapidly growing intersection of sports, media, and technology with key players including AWS, IMAX, NFL, and Microsoft. Thought leaders will explore opportunities to expand the fan experience and unlock new revenue streams.

Over 1,000 industry leaders will speak across more than 20 stages, and feature trailblazers who are capitalizing on new ways audiences consume content including:

  • Dhar Mann and Sean Atkins from Dhar Mann Studios – Dhar Mann was named Forbes’ second top creator in 2024 with an estimated 24 million YouTube followers and 120 million across various platforms.
  • Nick Khann, President & CEO and Paul “Triple H” Levesque, Chief Content Officer, WWE – recently signed a 10-year, $5 billion deal to bring RAW to Netflix.
  • Gotham Chopra – co-founder ROS (Religion of Sports). ROS is a full-service studio creating high-performance content including series like Simone Biles Rising; In the Arena: Serena Williams; and Kobe Bryant’s Muse.
  • Bobby Carter, host and producer of NPR’s Tiny Desk Concerts
  • Jody Gerson, Chairman and CEO of Universal Music Publishing Group
  • Portia Archer, CEO, Women’s Tennis Association
  • Tracey Perlman, SVP Player Operations, NFL
  • Jason McCourty, Super Bowl Champion, NFL Game Analyst, CBC
  • Tracy Dyson, Astronaut, NASA
  • Kevin Mayer and Tom Staggs, co-founders and co-CEOs, Candle Media
  • Steven A. Smith, Television Host, ESPN

Show Floor Experiences

NAB Show 2025 will also showcase interactive, immersive experiences, including:

  • Creator Lab: The ultimate destination for influencers, content creators, and digital storytellers looking to elevate their craft, grow their brands, and explore the latest tools shaping the creator economy.
  • AWS Racing Simulator: Test your driving skills, generate real time data, and experience the latest immersive entertainment content.

Building the Future of Content and Entertainment

NAB Show 2025 is projected to continue its year-over-year attendance growth and exceed over 60,000 registrations with attendees from 160 countries including 44 organized delegations - gathering to become part of the global content and entertainment landscape, where deals are made, and partnerships are forged. The show is attracting the next generation of storytellers with 50% of registrants attending NAB Show 2025 for the first time. Each year nearly $17 billion in business is generated through the connections made at NAB Show.

Registration is open for NAB Show. For the latest news and announcements, visit NABShow.com.

About NAB

The National Association of Broadcasters is the premier advocacy association for America’s broadcasters. NAB advances radio and television interests in legislative, regulatory and public affairs. Through advocacy, education and innovation, NAB enables broadcasters to best serve their communities, strengthen their businesses and seize new opportunities in the digital age. Learn more at www.nab.org.

About NAB Show

NAB Show is the preeminent conference and exhibition driving the evolution of broadcast, media and entertainment, held April 5-9, 2025 (Exhibits April 6-9) in Las Vegas. Produced by the National Association of Broadcasters, NAB Show is the ultimate marketplace for next-generation technology inspiring superior audio and video experiences. From creation to consumption, across multiple platforms, NAB Show is where global visionaries convene to bring content to life in new and exciting ways. Learn more at NABShow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250404420613/en/

Contacts

media@nabshow.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Microba Announces Landmark GI Study Results From Over 4,600 Patients15.5.2025 05:12:00 EEST | Press release

Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identify and address underlying gut issues that often go undetected by conventional testing. In over 70% of cases, the test revealed findings, such as abnormalities in gut bacteria, signs of infection, markers of inflammation or insufficiency that could inform targeted treatment strategies. Further, two-thirds of MetaXplore patients in a separate study of follow up survey results reported improvement of symptoms after their care was guided by the test results. This press release features multimedia. View the full release here: https://www.businesswire.

Bloomstreet Enters into Strategic Partnership Agreement with Google Israel for Market Expansion in Japan15.5.2025 05:00:00 EEST | Press release

Bloomstreet Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Junichi Takayama; hereinafter “Bloomstreet”), a company that supports overseas enterprises entering the Japanese market, is pleased to announce a strategic partnership agreement with Google Israel Ltd. (Headquarters: Tel Aviv District; Country Manager: Barak Regev; hereinafter “Google Israel”). This partnership aims to support Israeli companies that operate globally with Google Ads and are seeking to expand into the Japanese market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514387485/en/ How do Bloomstreet and Google Israel collaborate? The partnership between Bloomstreet and Google Israel is designed to support Israeli companies seeking to expand into the Japanese market by optimizing their website UI/UX, thereby enhancing the effectiveness of their Google Ads campaigns. Background of the Partnership Known as a "Start-up Nation," Israel is home to many

Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience15.5.2025 04:11:00 EEST | Press release

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that using open source codes integrated in the company’s broader propriety drug discovery platform, ALEMBIC™, helped to identify senescent neurons in a new study that found senescent neurons drive chronic pain with injury and age.1 Senescent cells, often called “zombie” cells, arise as the results of cellular stress and damage. These senescent cells do not die but undergo cellular changes, including secreting pro-inflammatory factors, thereby potentially contributing to inflammatory responses within the body.1 The study, led by Stanford University scientists, Vivianne Tawfik, MD, PhD, and Lauren Donovan, PhD, and co-authored by Rubedo team members, including Chief Scientific Officer Marco Quarta, PhD, and Chief Technology Officer Alex Laslavic, was published in the May 14th edition of Nat

The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 115.5.2025 00:03:00 EEST | Press release

Takeda (TSE: 4502/NYSE:TAK) today announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton (TAK-861) in people with narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to restore orexin signaling to address the underlying orexin deficiency that causes NT1. Results demonstrated significant improvement in objective and subjective measures of excessive daytime sleepiness (EDS), reductions in cataplexy events and clinically meaningful improvements in disease severity and quality of life across all doses tested compared to placebo through eight weeks of treatment. NT1 is a severe, chronic neurological condition caused by a significant loss of orexin-producing neurons, resulting in low levels of orexin leading to EDS, cataplexy (sudden loss of muscle tone), cognitive symptoms, disrupted nighttime sleep, hallucinations that occur as one falls asleep or wakes up and sleep paralysis.T

BeiGene Showcases Strength of Hematology Portfolio at EHA 2025 with New Data Highlighting BRUKINSA’s Leadership and Next-Generation Innovation14.5.2025 23:05:00 EEST | Press release

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share data across a range of hematologic malignancies at the European Hematology Association (EHA) Congress in Milan, Italy, June 12–15. BeiGene has 31 abstracts accepted at EHA 2025, with four selected for oral presentations, featuring data from its best-in-class Bruton’s tyrosine kinase (BTK) inhibitor BRUKINSA® (zanubrutinib) and its investigational pipeline assets – a next-generation BCL2 inhibitor, sonrotoclax, and BTK protein degrader, BGB-16673. These data reflect BeiGene’s vision to redefine standards of care in hematology through next-generation science and patient-focused innovation. “With three cornerstone hematology assets – BRUKINSA, sonrotoclax and BGB-16673 – we are advancing a potentially best-in-class portfolio in B-cell malignancies,” said Lai Wang, Ph.D. Global Head of R&D. “At EHA 2025, we’ll share 31 accepted ab

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye